North Growth Management’s Axonics, Inc. Common Stock AXNX Stock Holding History

North Growth Management’s Portfolio AXNX Stock Details AXNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-25,000	Closed	-$1.77M	–	48
2024 Q3	$1.77M	Hold	25,000	–	–	0.33%	44
2024 Q2	$1.71M	Hold	25,000	–	–	0.34%	43
2024 Q1	$1.75M	Sell	25,000 -1,000	-4%	-$67.5K	0.33%	44
2023 Q4	$1.59M	Hold	26,000	–	–	0.34%	44
2023 Q3	$1.44M	Buy	+26,000	New	+$1.46M	0.32%	46

Other funds holding AXNX

TCA

Taconic Capital Advisors New York $212M AUM 100.15% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

North Growth Management's AXNX Position: Q4 2024 in Review

North Growth Management sold out of Axonics, Inc. Common Stock (AXNX) in Q4 2024, closing a stake of 25,000 shares — an estimated $1.77M sold.

North Growth Management first reported a position in AXNX in Q3 2023 and held it in 5 quarters. The position peaked at $1.77M in Q3 2024. 2 funds tracked by Wall St. Rank hold AXNX as of Q4 2024.

North Growth Management reported no remaining Axonics, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
North Growth Management sold 25,000 Axonics, Inc. Common Stock shares in Q4 2024, an estimated $1.77M.
North Growth Management first reported a position in Axonics, Inc. Common Stock in Q3 2023 and held it in 5 quarters.
North Growth Management's Axonics, Inc. Common Stock position peaked at $1.77M in Q3 2024.
2 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q4 2024.

Based on North Growth Management's 13F filing for Q4 2024, filed 28 Jan 2025.